Average Co-Inventor Count = 5.64
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (59 from 1,829 patents)
2. Dendreon Corporation (5 from 53 patents)
3. Other (1 from 832,912 patents)
4. Schering-Plough Corporation (1 from 28 patents)
61 patents:
1. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
2. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
3. 7595299 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
4. 7485645 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
5. 7432268 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
6. 7425576 - Compounds as inhibitors of hepatitis C virus NS3 serine protease
7. 7423058 - Inhibitors of hepatitis C virus NS3 protease
8. 7271175 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
9. 7244721 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
10. 7205330 - Inhibitors of hepatitis C virus NS3 protease
11. 7186747 - Compounds as inhibitors of hepatitis C virus NS3 serine protease
12. 7169760 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
13. 7138396 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
14. 7115578 - Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
15. 7053091 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases